GL1X · GenesisL1 explorer

MolNFT v1 · #114669 · protein

Crystal structure of SIRT3 with a H3K9 peptide containing a myristoyl lysine

5BWN · Myristoyl H3K9 peptide: “Crystal structure of SIRT3 with a H3K9 peptide containing a myristoyl lysine”. X-ray diffraction, 1 ligand (ZN), 4 pockets (best druggability 0.59). MolNFT v1 #114669 on GenesisL1: 3D structure, binding…

PDB
5BWN
Type
protein
Length
283 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Myristoyl H3K9 peptide; NAD-dependent protein deacetylase sirtuin-3, mitochondrial
EC
3.5.1.-
UniProt
Q9NTG7
Ligands
ZN
Pockets
4 · best druggability 0.59

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BMyristoyl H3K9 peptideprotein90% helix, 22% strand—
ANAD-dependent protein deacetylase sirtuin-3, mitochondrial (EC 3.5.1.-)protein27442% helix, 18% strandQ9NTG7

Ligands and binding sites

  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11140.590.8517empty
21200.450.7823empty
31120.370.7426empty
4630.320.7616empty

Interfaces

1 interface between chains.

  • B–A · 781 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (nonstandard).

Compared structures

  • Q9NTG7 · AlphaFold monomer V2.0 prediction for NAD-dependent protein deacetylase sirtuin-3… · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.